Please join RedHill Biopharma for a Research & Development Day in New York City on April 27th.
Management to discuss BEKINDA (RHB-102) for Acute Gastroenteritis (Phase III) and IBS-D (Phase II).
Expert Guest Speakers to Include:
Robert A. Silverman, MD, MS
Lead Investigator, BEKINDA® Phase III Study
Emergency Medicine Specialist at the Hofstra North Shore-LIJ Medical Center, Associate Professor at the Hofstra Shore-LIJ School of Medicine in NY
Scott Harris, MD, MS, FACP, AGAF
Consultant to Redhill Biopharma
Center for Diagnostics and Therapeutics of the American Gastroenterological Assocation, Professor of Clinical Pharmacology and Physiology at Georgetown University School
Jerry Rosenblatt, PhD
Redhill Biopharma Advisory Board
Managing Director, Foster Rosenblatt
For more information or to RSVP please contact Kelly Mueller (email@example.com)